Journal of International Oncology››2016,Vol. 43››Issue (6): 405-408.doi:10.3760/cma.j.issn.1673-422X.2016.06.002
Previous ArticlesNext Articles
Liu Yunhe, Yu Jianchun, Jia Yingjie, Li Wentao, Xu Hongda
Received:
2015-06-04Online:
2016-06-08Published:
2016-04-27Contact:
Yu Jianchun E-mail:yujianchun@eyou.comSupported by:
National Natural Science Foundation of China (81273937); Specialized Research Fund for the Doctoral Program of Higher Education (20121210110010); Tianjin Cancer Major Research Plan (12ZCDZSY15800); Tianjin Science and Technology Commission of Science and Technology Support Plan (12CDZSY17000); Tianjin Health and Family Planning Commission Scientific Research Subject for Traditional Chinese Medicine and Combine Traditional Chinese and Western Medicine (2015090)
Liu Yunhe, Yu Jianchun, Jia Yingjie, Li Wentao, Xu Hongda. Analysis of the lymphocyte subsets of 508 cases of cancer patients[J]. Journal of International Oncology, 2016, 43(6): 405-408.
[1] Mandala WL, Ananworanich J, Apornpong T, et al. Control lymphocyte subsets: can one country′s values serve for another′s?[J]. J Allergy Clin Immunol, 2014, 134(3): 759-761.e8. DOI: 10.1016/j.jaci.2014.06.030. [2] Yang H, Wu Y, Li H, et al. Reference values of T lymphocyte subsets among health adults in Inner Mongolia Region[J]. Int J Clin Exp Med, 2015, 8(3): 4250-4256. [3] Riazi Rad F, Ajdary S, Omranipour R, et al. Comparative analysis of CD4+ and CD8+ T cells in tumor tissues, lymph nodes and the peripheral blood from patients with breast cancer[J]. Iran Biomed J, 2015, 19(1): 35-44. DOI: 10.6091/ibj.1289.2014. [4] Chen J, Yang J, Jiang J, et al. Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer[J]. Int J Clin Exp Pathol, 2014, 7(11): 8304-8311. [5] Zikos TA, Donnenberg AD, Landreneau RJ, et al. Lung Tcell subset composition at the time of surgical resection is a prognostic indicator in nonsmall cell lung cancer[J].Cancer Immunol Immunother, 2011, 60(6): 819-827. DOI: 10.1007/s00262-011-0996-4. |
[1] | Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325. |
[2] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[3] | Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369. |
[4] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[5] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[6] | Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238. |
[7] | Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165. |
[8] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[9] | Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82. |
[10] | He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36. |
[11] | Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer: present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58. |
[12] | Wang Jing, Xu Wenting.Value of NLR, CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526. |
[13] | Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531. |
[14] | Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456. |
[15] | Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||